- Home
- FOFO vs XTNT Comparison
FOFO vs XTNT Comparison
Compare FOFO & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOFO | XTNT |
|---|---|---|
| Founded | 2017 | N/A |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.2M | 82.6M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | FOFO | XTNT |
|---|---|---|
| Price | $5.74 | $0.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 64.6K | ★ 183.1K |
| Earning Date | 03-13-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | 0.01 |
| Revenue | $3,117,608.00 | ★ $133,083,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $15.35 | $54.90 |
| Revenue Growth | ★ 1597.65 | 16.88 |
| 52 Week Low | $4.53 | $0.34 |
| 52 Week High | $68.00 | $0.95 |
Technical Indicators
Market Signals| Indicator | FOFO | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 36.12 |
| Support Level | $5.56 | $0.60 |
| Resistance Level | $6.14 | $0.67 |
| Average True Range (ATR) | 0.50 | 0.05 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 16.82 | 5.07 |
Price Performance
Historical ComparisonAbout FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.